An IL-12-independent role for CD40-CD154 in mediating effector responses: Studies in cell-mediated glomerulonephritis and dermal delayed-type hypersensitivity

Journal of Immunology

Volumn 173, Issue 1, 2004, Pages 136-144

  Ruth, Amanda Jane ^a   Kitching, A Richard ^a   Li, Ming ^a   Semple, Timothy J ^a   Timoshanko, Jennifer R ^a   Tipping, Peter G ^a   Holdsworth, Stephen R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE; GAMMA INTERFERON; GLOBULIN; INTERLEUKIN 12; NEPHRITOGENIC ANTIGEN;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRESCENTIC GLOMERULONEPHRITIS; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; GLOMERULONEPHRITIS; IMMUNE INJURY; KIDNEY INJURY; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SKIN ALLERGY; TH1 CELL;

EID: 2942720779     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.1.136     Document Type: Article

References (46)

1. Vogel, L. A., and R. J. Noelle. 1998. CD40 and its crucial role as a member of the TNFR family. Semin. Immunol. 10:435.
2. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111.
3. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
4. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
5. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275.
6. Noelle, R. J. 1996. CD40 and its ligand in host defense. Immunity 4:415.
7. Shu, U., M. Kiniwa, C. Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125.
8. Wittmann, M., P. Kienlin, S. Mommert, A. Kapp, and T. Werfel. 2002. Suppression of IL-12 production by soluble CD40 ligand: evidence for involvement of the p44/42 mitogen-activated protein kinase pathway. J. Immunol. 168:3793.
9. + T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ dependent. Int. Immunol. 5:1119.
10. Stuber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693.
11. Stout, R. D., and J. Suttles. 1996. The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today 17:487.
12. Alderson, M. R., R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:669.
13. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
14. Hollenbaugh, D., N. Mischel-Petty, C. P. Edwards, J. C. Simon, R. W. Denfeld, P. A. Kiener, and A. Aruffo. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:33.
15. Karmann, K., C. C. Hughes, J. Schechner, W. C. Fanslow, and J. S. Pober. 1995. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 92:4342.
16. Holdsworth, S. R., A. R. Kitching, and P. G. Tipping. 1999. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int. 55:1198.
17. Huang, X. R., P. G. Tipping, J. Apostolopoulos, C. Oettinger, M. D'Souza, G. Milton, and S. R. Holdsworth. 1997. Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin. Exp. Immunol. 109:134.
18. Tipping, P. G., A. R. Kitching, M. A. Cunningham, and S. R. Holdsworth. 1999. Immunopathogenesis of crescentic glomerulonephritis. Curr. Opin. Nephrol. Hypertens. 8:281.
19. Li, S., C. Kurts, F. Kontgen, S. R. Holdsworth, and P. G. Tipping. 1998. Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J. Exp. Med. 188:597.
20. Ruth, A. J., A. R. Kitching, T. J. Semple, P. G. Tipping, and S. R. Holdsworth. 2003. Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis. J. Am. Soc. Nephrol. 14:2813.
21. Becher, B., B. G. Durell, A. V. Miga, W. F. Hickey, and R. J. Noelle. 2001. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 193:967.
22. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.
23. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76:34.
24. Kitching, A. R., S. R. Holdsworth, and P. G. Tipping. 1999. IFN-γ mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J. Am. Soc. Nephrol. 10:752.
25. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
26. Hess, H., M. K. Gately, E. Rude, E. Schmitt, J. Szeliga, and T. Germann. 1996. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant. Eur. J. Immunol. 26:187.
27. Tipping, P. G., A. R. Kitching, X. R. Huang, D. A. Mutch, and S. R. Holdsworth. 1997. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur. J. Immunol. 27:530.
28. Timoshanko, J. R., S. R. Holdsworth, A. R. Kitching, and P. G. Tipping. 2002. IFN-γ production by intrinsic renal cells and bone marrow-derived cells is required for full expression of crescentic glomerulonephritis in mice. J. Immunol. 168:4135.
29. Huang, X. R., S. R. Holdsworth, and P. G. Tipping. 1994. Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int. 46:69.
30. Timoshanko, J. R., A. R. Kitching, S. R. Holdsworth, and P. G. Tipping. 2001. Interleukin-12 from intrinsic cells is an effector of renal injury in crescentic glomerulonephritis. J. Am. Soc. Nephrol. 12:464.
31. Cunningham, M. A., X. R. Huang, J. P. Dowling, P. G. Tipping, and S. R. Holdsworth. 1999. Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J. Am. Soc. Nephrol. 10:499.
32. Madaio, M. P. 1999. The role of autoantibodies in the pathogenesis of lupus nephritis. Semin. Nephrol. 19:48.
33. Sexton, D. J., and D. Spelman. 2003. Current best practices and guidelines: assessment and management of complications in infective endocarditis. Cardiol. Clin. 21:273.
34. Adler, S., and W. Couser. 1985. Immunologic mechanisms of renal disease. Am. J. Med. Sci. 289:55.
35. Wilson, C. B. 1972. Immunological mechanisms of glomerulonephritis. Calif. Med. 116:56.
36. Gilliland, B. C. 1984. Serum sickness and immune complexes. N. Engl. J. Med. 311:1435.
37. Huang, X. R., P. G. Tipping, L. Shuo, and S. R. Holdsworth. 1997. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int. 51:94.
38. Tipping, P. G., and S. R. Holdsworth. 2003. T cells in glomerulonephritis. Springer Semin. Immunopathol. 24:377.
39. Kennedy, M. K., K. S. Picha, W. C. Fanslow, K. H. Grabstein, M. R. Alderson, K. N. Clifford, W. A. Chin, and K. M. Mohler. 1996. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26:370.
40. Kitching, A. R., P. G. Tipping, and S. R. Holdsworth. 1999. IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur. J. Immunol. 29:1.
41. Kehry, M. R. 1996. CD40-mediated signaling in B cells: balancing cell survival, growth, and death. J. Immunol. 156:2345.
42. Li, S., S. R. Holdsworth, and P. G. Tipping. 1997. Antibody independent crescentic glomerulonephritis in μ-chain deficient mice. Kidney Int. 51:672.
43. Tang, W. W., M. Qi, J. S. Warren, and G. Y. Van. 1997. Chemokine expression in experimental tubulointerstitial nephritis. J. Immunol. 159:870.
44. Cockwell, P., A. J. Howie, D. Adu, and C. O. Savage. 1998. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int. 54:827.
45. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
46. Tobin, J. F., S. L. Reiner, F. Hatam, S. Zheng, C. L. Leptak, D. F. Wirth, and R. M. Locksley. 1993. Transfected Leishmania expressing biologically active IFN-γ. J. Immunol. 150:5059.